Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway

被引:42
作者
Delhanty, P. J. D.
van Koetsveld, P. M.
Gauna, C.
van de Zande, B.
Vitale, G.
Hofland, L. J.
van der Lely, A. J.
机构
[1] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands
[2] Univ Milan, Fac Med, Chair Endocrinol, Ist Auxol Italiano, I-20122 Milan, Italy
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2007年 / 293卷 / 01期
关键词
unacylated ghrelin;
D O I
10.1152/ajpendo.00377.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ghrelin is expressed in normal human adrenocortical cells and induces their proliferation through growth hormone secretagogue receptor la (GHS-R1a). Consequently, it was of interest to us to determine whether acylated ghrelin and its predominant serum isoform, unacylated ghrelin, also act as factors for adrenocortical carcinoma cell growth. To examine a potential ghrelin-regulated system in adrenocortical tumors, we measured proliferative effects of acylated and unacylated ghrelin in the adrenocortical carcinoma cell lines SW-13 and NCI-H295R. We also examined the expression of ghrelin, GHSR1a, and corticotrophin-releasing factor receptor 2 (CRF-R2). Acylated and unacylated ghrelin in the nanomolar range dose-dependently induced adrenocortical cell growth up to 200% of untreated controls, as measured by thymidine uptake and WST1 assay. The proliferative effects of acylated and unacylated ghrelin in SW-13 cells was blocked by [D-Lys(3)]growth hormone-releasing peptide 6 (GHRP6), but a CRF-R2 antagonist had no effect on unacylated ghrelin growth stimulation. Cell cycle analysis suggests that acylated and unacylated ghrelin suppress the sub-G(0)/apoptotic fraction by up to 50%. Measurement of DNA fragmentation and caspase-3 and -7 activity in SW-13 cells confirmed that acylated and unacylated ghrelin suppress apoptotic rate. SW-13 cells express preproghrelin mRNA and secrete ghrelin, and [D-Lys(3)]GHRP6 suppresses their basal proliferation rate, strongly suggesting that ghrelin could act as an amo/paracrine growth factor. Acylated and unacylated ghrelin are potential amo/paracrine factors acting through an antiapoptotic pathway to stimulate adrenocortical tumor cell growth. Unacylated ghrelin-stimulated growth is suppressed by an antagonist of GHS-R1a, suggesting either that unacylated ghrelin is acylated before its action or that ghrelin, unacylated ghrelin, and [D-Lys(3)]GHRP-6 bind to a novel receptor in these cells.
引用
收藏
页码:E302 / E309
页数:8
相关论文
共 39 条
[11]   Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy [J].
de Fraipont, F ;
El Atifi, M ;
Cherradi, N ;
Le Moigne, G ;
Defaye, G ;
Houlgatte, R ;
Bertherat, J ;
Bertagna, X ;
Plouin, PF ;
Baudin, E ;
Berger, F ;
Gicquel, C ;
Chabre, O ;
Feige, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1819-1829
[12]   Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites [J].
De Vriese, C ;
Gregoire, F ;
Lema-Kisoka, R ;
Waelbroeck, M ;
Robberecht, P ;
Delporte, C .
ENDOCRINOLOGY, 2004, 145 (11) :4997-5005
[13]   Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a [J].
Delhanty, PJD ;
van der Eerden, BCJ ;
van der Velde, M ;
Gauna, C ;
Pols, HAP ;
Jahr, H ;
Chiba, H ;
van der Lely, AJ ;
van Leeuwen, JPTM .
JOURNAL OF ENDOCRINOLOGY, 2006, 188 (01) :37-47
[14]   Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes [J].
Gauna, C ;
Delhanty, PJD ;
Hofland, LJ ;
Janssen, JAMJL ;
Broglio, F ;
Ross, RJM ;
Ghigo, E ;
van der Lely, AJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :1055-1060
[15]   The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans [J].
Gnanapavan, S ;
Kola, B ;
Bustin, SA ;
Morris, DG ;
McGee, P ;
Fairclough, P ;
Bhattacharya, S ;
Carpenter, R ;
Grossman, AB ;
Korbonits, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2988-2991
[16]   ABSENCE OF INTERMEDIATE FILAMENTS IN A HUMAN ADRENAL-CORTEX CARCINOMA-DERIVED CELL-LINE [J].
HEDBERG, KK ;
CHEN, LB .
EXPERIMENTAL CELL RESEARCH, 1986, 163 (02) :509-517
[17]   The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro [J].
Hofland, LJ ;
van der Hoek, J ;
van Koetsveld, PM ;
de Herder, WW ;
Waaijers, M ;
Sprij-Mooij, D ;
Bruns, C ;
Weckbecker, G ;
Feelders, R ;
van der Lely, AJ ;
Beckers, A ;
Lamberts, SWJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1577-1585
[18]   High constitutive signaling of the ghrelin receptor - Identification of a potent inverse agonist [J].
Holst, B ;
Cygankiewicz, A ;
Jensen, TH ;
Ankersen, M ;
Schwartz, TW .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (11) :2201-2210
[19]   A receptor in pituitary and hypothalamus that functions in growth hormone release [J].
Howard, AD ;
Feighner, SD ;
Cully, DF ;
Arena, JP ;
Liberator, PA ;
Rosenblum, CI ;
Hamelin, M ;
Hreniuk, DL ;
Palyha, OC ;
Anderson, J ;
Paress, PS ;
Diaz, C ;
Chou, M ;
Liu, KK ;
McKee, KK ;
Pong, SS ;
Chaung, LY ;
Elbrecht, A ;
Dashkevicz, M ;
Heavens, R ;
Rigby, M ;
Sirinathsinghji, DJS ;
Dean, DC ;
Melillo, DG ;
Patchett, AA ;
Nargund, R ;
Griffin, PR ;
DeMartino, JA ;
Gupta, SK ;
Schaeffer, JM ;
Smith, RG ;
VanderPloeg, LHT .
SCIENCE, 1996, 273 (5277) :974-977
[20]   The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer [J].
Jeffery, PL ;
Herington, AC ;
Chopin, LK .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (02) :113-122